Oncology Venture receives response from the FDA to the IND-application and proposed pivotal study for LiPlaCis


You May Also Like

CohBar Announces the Appointment of Dr. John Amatruda to its Board

MENLO PARK, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an ...

Interpace Diagnostics Announces Expansion of LabCorp National Agreement

PARSIPPANY, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...